汽化电切中叶并单侧叶治疗高危重度前列腺增生症

Treatment of high risk and large volume benign prostatic hyperplasia by transurethral electrovaporization of prostate of middle and single lobe

目的探讨经尿道前列腺中叶并单侧叶汽化电切术(TUVRP)治疗高危重度前列腺增生(BPH)的安全性及疗效。方法回顾性分析248例高危重度BPH患者行经尿道前列腺中叶并单侧叶的TUVRP临床资料。结果本组患者均安全度过围手术期,无电切综合症、大量失血发生,排尿功能明显改善。术后随访3月～36月,国际前列腺症状评分(IPSS)由术前(28.6±3.3)分降至(9.1±2.3)分,生活质量评分(QOL)由(4.5±0.2)分降至(2.1±0.2)分,最大尿流率由(6.3±0.3)ml/s提高至(17.4±0.2)ml/s,剩余尿量由(192±13)ml降至(19.5±12.3)ml。结论经尿道前列腺中叶并单侧叶汽化电切术手术时间短,出血量少,安全有效,适合于高危重度BPH的治疗。

Objective To investigate the safety and therapeutic effect of transurethral electrovaporization（TUVRP） of single and middle lobe in treatment of high risk and large volume benign prostatic hyperplasia（BPH）.Methods The clinical data of 248 old patients with high risk and large volume benign prostatic hyperplasia underwent transurethral electrovaporization of single and middle lobe were analyzed retrospectively.Results The perioperative period all patients was uneventful,No patients experienced TUR syndrome and serious bleeding,the urination function improved significantly.After the follow up 3~36 months,the IPSSdecreased from（28.6±3.3）to（9.1±2.3）,the QOL Decreased from（4.5±0.2）to（2.1±0.2）,the maximum urinary flow rate increased from（6.3±0.3）ml/s to（17.4±0.2）ml/s,the residual urine volume decreased from（192±13）ml to（19.5±12.3）ml.Conclusion Transurethral electrovaporization of prostate of single and middle lobe was an operative method with less bleeding,shorter operative time,safe and efficacious.It＇s suitable for the treatment of high risk and large volume benign prostatic hyperplasia.